Clinical Trial
Auranofin in the treatment of rheumatoid arthritis. A two-year study
- PMID: 3934512
Item in Clipboard
Clinical Trial
Auranofin in the treatment of rheumatoid arthritis. A two-year study
Mo Med.
1985 Nov.
No abstract available
Similar articles
-
A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.Int J Clin Pharmacol Res. 1984;4(6):395-401. Int J Clin Pharmacol Res. 1984. PMID: 6442711 Clinical Trial.
-
[Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].Wien Klin Wochenschr Suppl. 1984;156:49-51. Wien Klin Wochenschr Suppl. 1984. PMID: 6442058 German. No abstract available.
-
Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.J Rheumatol Suppl. 1982 Jul-Aug;8:184-9. J Rheumatol Suppl. 1982. PMID: 6813483 Clinical Trial.
-
Worldwide clinical experience with auranofin.Clin Rheumatol. 1984 Mar;3 Suppl 1:105-11. doi: 10.1007/BF03342628. Clin Rheumatol. 1984. PMID: 6432408 Review. No abstract available.
-
[Experiences to date with oral gold therapy].Wien Klin Wochenschr Suppl. 1984;156:22-7. Wien Klin Wochenschr Suppl. 1984. PMID: 6442052 Review. German.
Cited by
-
Auranofin versus placebo in rheumatoid arthritis.Cochrane Database Syst Rev. 2000;2000(2):CD002048. doi: 10.1002/14651858.CD002048. Cochrane Database Syst Rev. 2000. PMID: 10796461 Free PMC article.
-
Black phosphorus-Au-thiosugar nanosheets mediated photothermal induced anti-tumor effect enhancement by promoting infiltration of NK cells in hepatocellular carcinoma.J Nanobiotechnology. 2022 Feb 21;20(1):90. doi: 10.1186/s12951-022-01286-z. J Nanobiotechnology. 2022. PMID: 35189896 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical